# clm_D6451915A936

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_net_income  
value: 722,000,000 United States dollar  
valid_from: 2024-03-31  
valid_to: 2024-06-30  
published: 2024-05-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_01E985023556  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly net income: 722,000,000 United States dollar", as of 2024-03-31 (until 2024-06-30). Claim clm_D6451915A936, https://asof.is/claim/clm_D6451915A936, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422024000017/0001804220-24-000017-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q1 FY2024, filed 2024-05-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422024000017/0001804220-24-000017-index.htm (primary, SEC EDGAR 10-Q Q1 FY2024, published 2024-05-02)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,007,800,000 United States dollar | valid 2023-09-30 to 2024-03-31 | conf 0.95 | superseded | superseded_by [clm_D6451915A936](/claim/clm_D6451915A936.md) | [clm_0089CAC97396](/claim/clm_0089CAC97396.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.